Bibliography

153

BIBLIOGRAPHY

A. I. Juwah, E. U. Nlemadim, W. Kaine. Types of anaemic crisis in

paediatric patients with sickle cell anaemia seen in Enugu, Nigeria.

Arch Dis Child. 2004; 89: 572-576.

A. V. Shrikhande, A. A. Dani, J. R. Tijare, A. K. Agrawal. Hematological

profile of sickle cell disease in central India. Indian J. Hematol. Blood

Transfus. 2003; (3–4): 92–98.

A. M. Emokpae, P. O. Uadia, and A. Kuliya-Gwarzo. Antioxidant enzymes

and acute phase proteins correlate with marker of lipid peroxide in

adult Nigerian sickle cell disease patients. Iranian Journal of Basic

Medical Sciences. 2010; 13(4): 177–182.

A.J. Duits, H. Ten Cate, and D.P.M. Brandjes. Protein C and S and

Inflammation in Sickle Cell Disease. American Journal of Hematology .

2004; 76: 26–32

Abhay Bhave, V.K. Kulkarni, D.N. Bhattad, D.P. Upase, Aarti Mane, Colah

Roshan, Khushnuma. Microcytic Hypochromic Anaemia in Sickle Cell

disease- Think again. JAPI. 2009; 57: 479-480.

Adelekan D.A., Thurnham D.I., Adekile A.D. Reduced antioxidant

capacity in pediatric patients with homozygous sickle cell disease. Eur J

Clin Nutr. 1989; 43: 609-14.

Aebi H. Catalase in vitro. Methods Enzymolgy. 1984; 105: 121-126.

Bibliography

154

Afonja O.A. Osteoblastic activity in sickle cell disease. Clin Chem

Newsletter. 1982; 3: 161-163.

Agil A., Sadrzadeh S.M. Hydroxy-urea protects erythrocytes against

oxidative damage. Redox Rep. 2000; 5: 29–34.

Agrawal M.B. The burden of haemoglobinopathies in India- time to

wake up. J Acad Phys Ind. 2005; 53: 1017-1018.

Akinsegun Akinbami, Adedoyin Dosunmu, Adewumi Adediran .Steady

state hemoglobin concentration and packed cell volume in homozygous

sickle cell disease patients in Lagos, Nigeria. Caspian J Intern Med

2012; 3(2): 405-409

Akohoue S.A., Shankar S., Milne G.L. morrow J., Chen Y. K., Ajay U.W.,

Buschowski S.M., Energy expenditure, inflammation, and oxidative

stress in steady state adolescents with sickle cell anemia. Pediatr Res.

2007; 61(2): 233-238.

Alsultan A. I., Seif M. A., Amin T. T., Naboli, M., Alsuliman A. M.

Relationship between oxidative stress, ferritin and insulin resistance in

sickle cell disease. Eur. Rev. Med. Pharmacol. Sci. 2010; 14: 527–538.

Ames, Cathcart, Schwiers, Hochstein. Uric acid provides antioxidant

defense in humans against radical caused ageing, cancer: A hypothesis.

1981; 78(11): 6858-6862.

Bibliography

155

Amstad P., Peskin A., Shah G., Mirault E.M., Moret R., Zbiden I., Cerutti P.

The balance between Cu,Zn-superoxide dismutase and catalase affects

the sensitivity of mouse epidermal cell to oxidative stress.

Biochemistry. 1991; 30: 9305-9313.

Angela D. Burnette, Shahid M. Nimjee, Milena Batchvarova, Rahima

Zennadi, Marilyn J. Telen, Jun-ichi Nishimura, and Bruce A. Sullenger,

.RNA Aptamer Therapy for Vaso-Occlusion in Sickle Cell Disease.

Nucleic acid therapeutics. 2011; 21(4):18.

Anil Pathare, Salam Al Kindi, Adel Alwan Alnaqdy, Shahina Daar, Huxley

Knox-Macaulay, and David Dennison. Cytokine profile of sickle cell

disease in Oman .American journal of Hematology 2004; 77: 323-328.

Anna Bogdanova, Asya Makhro, Jue Wang, Peter Lipp and Lars Kaestner

. Calcium in Red Blood Cells—A Perilous Balance. Int. J. Mol. Sci. 2013;

14: 9848-9872.

Antunes F., Salvador A., Marinho H.S., Alves R., Pinto R.E. Lipid

peroxidation in mitochondrial inner membranes. An integrative kinetic

model. Free Radic Biol Med. 1996; 21: 917-943.

Arlet J.B., Ribeil J.A., Chatellier G., Pouchot J.E., Montalembert M., Prie D.,

Courbebaisse M. hyperuricemia in sickle cell disease in France. Rev

Meed interne. 2012 ; 33(1): 13-7.

Bibliography

156

Ashfaq S., Abramson J.L., Jones D.P.,Rhodes D.S., Weintraub S.W>,

Hooper C.W., Vaccarino V., Harrison G. D., Qauumi A.A. The

relationship between plasma levels of oxidized and reduced thiols and

early atherosclerosis in healthy adults. J Am Coll Cardiol. 2006; 47(5):

1005-1011.

Ayekyaw. A simple colorimetric method for ascorbic acid

determination in blood plasma. Clin Chim Acta. 1978; 86: 153-157.

Ayodele Adelakun, Olumide Ajani, Temitope Ogunleye, Elizabeth Disu,

Ayokulehin Kosoko and Ganiyu Arinola. Respiratory Burst Enzymes

and Oxidantantioxidant Status in Nigerian Children with Sickle Cell

Disease. British Biotechnology Journal. 2014; 4(3):270-278.

Baker H. Frank O. Warley’s practical Clinical Biochemistry 1968 ; sixth

edition chapter 35 : 902-905.

Benkerrou M., Delarche C., Brahimi L., Fay M., Vimlma E. Elion J.,

Gougerot- Pocidalo M.A., Elbim C. Hydroxyurea corrects the

dysregulated L-selectin expression and increased H2O2 production of

polymorphonuclear neutrophils from patients with sickle cell anemia.

Blood. 2002; 99(7): 2297–303.

Beutler E., Duron O. & Kefly B. M. Improved method for the

determination of blood glutathione. J. Lab. Clin. Med. 1963; 61: 882-8.

Bibliography

157

Bradley And Hornbeck, Warley’s practical Clinical Biochemistry 1968 ;

1: sixth edition chapter 35.

Brugnara C. Reticulocyte cellular indices: A new approach in the

diagnosis of anemias and monitoring of erythropoietic function. Crit.

Rev Clin Lab Sci. 200; 37(2): 93-130.

Bunn H.F. Pathogenesis and treatment of sickle cell disease. N Engl J

Med. 1997; 337: 762 - 769.

Capo C., Bongrand P. Benoliel AM, Depieds R: Non-specific recognition

in phagocytosis: Ingestion of alde-hyde-treated erythrocytes by rat

peritoneal macro-phages. Immunology 1979; 36: 501-508.

Carlo Bruagnara. Red cell dehydration in pathophysiology and

treatment of sickle cell disese. HMS boston. December 2000.

Cerqueira B.A., Boas W.V., Zanette A.D., Reis M.G., Goncalves M.S.

Increased concentrations of IL-18 and uric acid in sickle cell anemia:

contribution of hemolysis, endothelial activation and the

inflammasome. Cytokine. Nov. 2011; 56 (2): 471-6.

Chen, Wilfred U. Ajayi, and Maciej S. Buchowski. Energy Expenditure,

Inflammation, and oxidative stress in steady-state adolescents with

Sickle Cell Anemia. Pediatr Res 2007; 61: 233–238.

Chirico, E. N.; Pialoux, V. Role of oxidative stress in the pathogenesis of

sickle cell disease. IUBMB Life. 2012; 64: 72–80.

Bibliography

158

Charache S., Lubin B.L., Reid C.D. . Management and therapy of sickle cell

disease. U.S. department of health and nutrition services, public health

service, National institute of health, NIH publication. 92:2117.

Claudia R. Morris, Gregory J. Kato, Mirjana Poljakovic, Xunde Wang

William C. Blackwelder, Vandana Sanchdev, M, Stanley L. Hazen, Elliott

P. Vichinsky, Sidney M. Morris Jr., Mark T. Gladwin. Dysregulated

Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension

and Mortality in Sickle Cell Disease. JAMA. 2005; 294(1): 81–90.

Clayton Natta, and Lawrence Machlin Clayton Natta,, and Lawrence

Machlin.. Plasma levels of tocopherol in sickle cell anemia subjects. The

American Journal of Clinical Nutrition. 1979; 32: 1359-1362.

Coletta M., Hofrichter J., Ferrone F.A., Eaton W.A. Kinetics of sickle

haemoglobin polymerization in single red cells. Nature

.1982;300(5888):194-197.

Creary M., Williamson D., & Kulkarini R. Sickle cell disease: current

Acivities, public health, implication and future direction . Journal of

women’s health.2007;16(5): 575-578.

D. Koracevic, G. Koracevic, V. Djordjevic, S. Andrejevic, V. Cosic .

Method for the measurement of antioxidant activity in human fluids. J

Clin Pathol 2001; 54: 356–361.

Bibliography

159

D. G. Hafeman, R. A. Sunde andw. G. Hoekstra. Effect of Dietary

Selenium on Erythrocyte and Liver Glutathione Peroxidase in the Rat. J.

Nutr. 1974; 104: 580-587.

Darcielle Bruna Dias Elias, ronelia Pinhiro Goncolvet. Evaluation of the

concentration of Malondialdehyde and nitrite in patients with sickle

cell anemia treated or not with hydroxyurea einstein. 2010; 8(4 Pt 1):

414-8.

Das, S. K., Nair, R. C. . Superoxide dismutase, glutathione peroxidase,

Catalase and lipid peroxidation of normal and sickled erythrocytes. Br.

J. Haematol. 1980; 44: 87–92.

Dasgupta, T., Hebbel, R. P., Kaul, D. K. Protective effect of arginine on

oxidative stress in transgenic sickle mouse models. Free Radic. Biol.

Med. 2006; 41: 1771–1780.

Debes Ray, Pradeep Deshmukh, Kalayan Goswani, Neelam Garg,

Antioxidant Vitamin levels in sickle cell disoeder. Natl. Med J India,

2007; 20: 11-13.

Dehghan A., Kardys I., DeMaat M.P., Uitterlinden A.G., Sijbrands E.J.,

Bootsma A.H., Stijnen T., Hofman A., Scram M.T. and Witteman J.C.

Genetic variation, C-reactive protein levels and incidence of diabetes.

Diabetes. 2008 56(3): 872-878.

Bibliography

160

Droge W. Free radicals in the physiological control of cell function.

Physiol Rev 2002; 82(1): 47-95.

E. S. Klings and H. W. Farber. Role of free radicals in the pathogenesis of

acute chest syndrome in sickle cell disease. Respiratory Research.

2001; 2(5): 280–285.

E.M. Isoa. Current event in the management of sickle cell disease : an

review . Benin Journal of Postgraduate Medicine . 2009; 11( suppl.

Dec).

Edis belini junior , Danilo Griling humberto da Silva, Lidiane de Spouza

Torres, Eduardo Alves de Almeida, Rodalfo Delfini Cancado, carlos

Chiattone Claudia Regina Bonini Domingos. Oxidative stress and

antioxidants capacity in sickle cell anemia patients receiving different

treatment and medication for different periods of time. Ann hematol

.2012; 91: 479-489.

Elizabeth M. Barden, Deborah A. Kawchak, Kwaku Ohene-Frempong,

Virginia A. Stallings, and Babette S. Zemel. Body composition in

children with sickle cell disease. Am J Clin Nutr 2002; 76: 218–25.

Enika Nagababu, Mary E. Fabry, Ronald L. Nagel, and Joseph M. Rifkind.

Heme Degradation and Oxidative Stress in Murine Models for

Hemoglobinopathies: Thalassemia, Sickle Cell Disease and Hemoglobin

C Disease. Blood Cells Mol Dis. 2008; 41(1): 60-66.

Bibliography

161

Erfan Nur , Bart J. Biemond, Hans-Martin Otten, Dees P. Brandjes, John-

John B. Schnog. Oxidative stress in sickle cell disease: pathophysiology

andpotential implications for disease management. Am. J. Hematol.

2011; 86:484–489.

Essien E.U.. Plasma levels of retinol, ascotbic acid and alfa- Tocopherol

in sickle cll anemia. Cent Afr J Med. 1995; 41(2): 48-50.

Ezeiruaku, F.C., Eze, E. M. and Ukaji, D. C. Activity Levels of Some

Erythrocyte Enzymes (Glutathione STransferase, Nadh Ferricyanide

Reductase) and Serum Lactate Dehydrogenase in the Three Human

Genotype (Hbss, Hbaa And Hbas) in southern Nigeria. JETEAS.

2(2):314-317.

Filiz Simsek, Gulyuz Ozturk, Sabri Kemahlı, Deniz Erbas, Alev

Hasanoglu. Oxidant and antioxidant status in beta thalassemia major

patients. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2005; 58: 34-38.

Foluke Fasola,Kayode Adedapo,John Anetor, and Modupe Kuti, .Total

Antioxidants Status and SomemHematological Values in Sickle Cell

Disease Patients in Steady State . Journal of the national medical

association. 2007; 99(8): 891.

Bunn H.F. Pathogenesis and treatment of sickle cell disease. N Engl J

Med 1997; 337:762-769.

Bibliography

162

G. Wu, Y.Z. Fang, S. Yang, J. R. Lupton, and N. D. Turner, Glutathione

Metabolism and Its Implications for Health. Journal of Nutrition. 2004;

134(3): 489–492.

Gizi A., Papasstiriou I., Apostolakou F., Lazaropoulou C., Papastamataki

M., Kanaski I., Kalotychou V., Gousstis E., Kattamis A. , Rombos I.,

Kanavakis E. . Assessment of oxidative stress in patients with sickle

cell disease: the glutathione system and oxidant- antioxidant status.

Blood cells Mil Djs. 2011; 46(3): 220-5.

Halliwell B, Gutteridge J.M. Lipid peroxidation, oxygen radicals, cell

damage, and antioxidant therapy. Lancet 1984; 1(83): 1396-1397.

Halliwell B. and Gutteridge J. M. C. Oxygen free radicals and iron in

relation to biology and medicine: Some problems and conceptsArch.

Biochem. Biophys. 1986 ; 246: 501-514.

Harper’s illustrated Biochmeistry 28th Edition . Mc Gra Hill.

Haynes J. Jr, Obiako B. . Activated polymorphonuclear cells increase

sickle red blood cell retention in lung: Role of phospholipids. Am. J.

Physiol. Heart Circ. Physiol. 2002; 282: H122–30.

Hebbel R.P., Eaton I.W., Balasingam M., Steinberg M.H. . Spontaneous

oxygen radical generation by sickle eryth-rocytes. J Clin Invest. 1982;

70: 1253-1259.

Bibliography

163

Hebbel R.P., Miller W.J. Phagocytosis of sickle erythrocytes:

immunologic and oxidative determinants of hemolytic anemia. Blood.

1984; 64: 733.

Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E.. Accelerated

autoxidation and heme loss due to instability of sickle hemoglobin.

Proc Natl Acad Sci U S A. 1988; 85(1): 237-241.

Hebbel R.P., Osarogiagbon R., Kaul D. The endothelial biology of sickle

cell disease: inflammation and a chronic vasculopathy. Microcirculation

.2004; 11: 129-51.

Hebbel R.P. Beyond hemoglobin polymerization: The red blood cell

membrane and sickle disease pathophysiology.Blood.1991;77: 214–37.

Hebbel R.P. The systems biology-based argument for taking a bold step

in chemoprophylaxis of sickle vasculopathy. Am J Hematol 2009; 84(9):

543-545.

Horn H.D., Bergmeyer H.U. Glutathione reductase: Methods of

Enzymatic Analysis. New York: Academic Press. 1963: 875-81.

Imoru Momodu, kabiru Sulelman, Shehu Abdullahi, Umar A. Shehu.

Haematological values in Nigerian children with steady state

homozygous sickle cell disease. Intenational journal of academic

research. 2011; 3(1).

Bibliography

164

Inwald D.P., Kirkham F.J., Peters M.J., Lane R., Wade A., Evans J.P., Klein

N.J. Platelet and leucocyte activation in childhood sickle cell disease:

association with nocturnal hypoxaemia. Br J Haematol 2000; 111: 474-

81.

J.B. Schnog, M.R. Mac Gillavry, A.P. van Zanten, J.C.M. Meijers, R.A. Rojer,

J.B.Harlan, Martin F Goldberg. Management and therapy of eye related

disorder in sickle cell disese. 2000.

Jaonne Thompson, Marvin Reid, Ian Hambleton, Graham R. Serjeant.

Albuminuria and renal function in homogyzous sickle cell disease. Arch

intern Med. 2007; 167: 701-708,

Jean C.D., Maryse T., Marie J.F. . Plasma M.alondialdehyde levels during

myocardial infarction. Clin Chim Acta 1983; 129: 319-22.

Jison M.L., Munson P.J., Barb J.J., Sufredini A.F., Talwar S., Logun

C., Raghavachari N., Beigel J.H., Shelhamer J.H., Danner R.L., Gladwin

M.T. Blood mononuclear cell gene expression profiles characterize the

oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood

2004; 104: 270–80.

Joan Schall, Babette I.S. Zemel , Deborah A. Kawchak M.S., Kwaku Ohene-

Frempong , Virginia. Vitamin A status, hospitalizations, and other

outcomes in young children with sickle cell disease. JPDES. 2004; 03:

51.

Bibliography

165

Johnkennedy Nnodim, Meludu Samuel C., Dioka C.E., Ihim Augustine,

Jones D.P.. Redox potential of GSH/GSSG couple: assay and biological

significance. Methods Enzymol 2002; 348: 93-112.

Joy Okpuzor, Olumide Adebesin, Henriatta Ogbunugafor, Ifeanyi Amadi.

The potential of medicinal plants in sickle cell disease control: A

review. International journal of Biomedical and health science 2008;

4(2): 47-55.

Jyoti Titus, Suresh Chari, Madhur Gupta, and Nitin Parekh . Pro-oxidant

and anti-oxidant status in patients of sickle cell anaemia, Indian Journal

of Clinical Biochemistry, 2004; 19 (2) 168-172.

Kalyan Goswami and Debes Ray. Putative pathogenic effect of oxidative

effect of oxidative stress in sickle cell disorder. Biomedical research,

2011; 22(1): 33-37.

Karl A. Nath, Joseph P. Grande, Jill J. Haggard, Anthony J. Croatt,

Zvonimir S. Katusic, Anna Solovey, and Robert P. Hebbel. Oxidative

Stress and Induction of Heme Oxygenase-1 in the Kidney in Sickle Cell

Disease. American Journal of Pathology. 2001;158(3): 893-903.

Kassab-Chekir, S. Laradi, S. Ferchichi. Oxidant, antioxi-dant status and

metabolic data in patientswith beta-thalassemia. ClinChimActa, vol.

2003. 338: 79-86.

Bibliography

166

Katherine C. Wood and D. Neil Granger. Sickle cell disease: Role of

reactive oxygen and nitrogen metabolites. Clinical and experimental

pharmacology and physiology 2007; 34: 926-932.

Kaul, D.K, Liu, X.D., Zhang, X., Ma, L., Hsia, C.J., Nagel, R.L. Inhibition of

sickle red cell adhesion and vasoocclusion in the microcirculation by

antioxidants. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: 167-175.

Kaul, D.K. and Hebbel, R.P. Hypoxia/reoxygenation causes inflammatory

response in transgenic sickle mice but not in normal mice. J. Clin.

Invest, 2000; 106: 411-420.

Kenneth I. Ataga,Charity G. Moore,Cheryl A. Hillery,Susan Jones,Herbert

C. Whinna,Dell Strayhorn,Cathy Sohier, Alan Hinderliter,Leslie V.

Parise, and Eugene P. Orringer. Coagulation activation and

inflammation in sickle cell disease associated pulmonary hypertension.

Haematologica. 2008; 93(1): 20-26.

Kibileri Williams, Maria Rios, Nicole Dottin, Shani Hughes, Danielle

Strachan, Gershwin Davis, Kenneth S. Charles and Terence A.R.

Seemungal. Lung Function and Inflammation in Adult Sickle Cell

Disease in a West Indian Sickle Cell Cohort. J Pulmon Resp Med. 2012:

2: 5

Bibliography

167

Klings E.S., Farber H.W. Role of free radicals in the pathogenesis of

acute chest syndrome in sickle cell disease. Respir Res. 2001; 2(5):

280-285.

Kootathep S., Situnayake R.D., Thurnham D.I.,Chirico S, Lunec J, Davis

M, McConkey B. Chain breaking antioxidant status in rheumatoid

arthritis: clinical and laboratory correlates. Ann Rheum Dis. 1991; 50:

81-6.

L.M.S. Viana-Baracioli1, N.C. Tukamoto Junior, O. Ricci Junior, L.C. Matto,

I.L. Ângulo and C.R. Bonini-Domingo. Comparison of oxidative stress

and the frequency of polymorphisms in the HFE gene between

hemoglobin S trait blood donors and sickle cell disease patients.

Genetics and Molecular Research. 2011; 10(4): 3446-3454.

M. A. Emokpae, P. O. Uadia, and A. A. Gadzama. Correlation of oxidative

stress and inflammatory markers with the severity of sickle cell

nephropathy. Annals of African Medicine.2010; 9(3) 141–146.

Macy , E.M. , Hayes, T.E. & Tracy, R.P. variability in the measurement of

C- reactive protein in healthy subjects. Implications for reference

inrtervals and epidemiological applicatios. Clinical chemistry. 1997; 43:

52-58.

Manfredini V., Lazzaretti L.L., Griebeler I.H., Santin A.P., Brandão

V.D., Wagner S., Castro S.M., Peralba M.D.C., Benfato M.S. . Blood

Bibliography

168

antioxidant parameter in sickle anemia in steady state. J natl. Med.

Assoc. 2008; 100(8): 897-902.

Mariane D.E. Montalembert,Yacine Aggoun, Assa Niakate, Isabelle

Szezepanski, Damien Bonnet. Endothelial-dependent vasodilation is

impaired in children with sickle cell disease. The hematology journal,

2007; 92(12): 1709.

Mayes P.A., Murray R.K., Granner D.K., Mayes P.A., Rodwell V.W. (eds).

Structure and function of the water-soluble vitamins. In Harper’s

biochemistry. 25th ed. Stamford, Connecticut: Appleton and Lange.

2000: 642–52.

Mohammed F.A., Mahdi N., Sater M.A., Al-Ola K., Almawi W.Y. . The

relation of C-reactive protein to vasoocclusive crisis in children with

sickle cell disease. Blood Cells Mol Dis. 2010; 45: 293–6.

Mohsen A. F. El-Hazmi, Arjumand S. Warsy. The clinical, hematological

and biochemical expression of hemoglobin S (Hb S) in the Eastern

Saudi Arabia, journal of islamic academy of sciences. 1991; 4(2): 149-

158,

Morris, C. R. Suh, J. H. Hagar, W. Larkin, S.Bland, D. A. Steinberg, M. H.

Vichinsky, E. P. Shigenaga, M. Ames, B. Kuypers, F. A, Klings, E. S.

Erythrocyte glutamine depletion, altered redox environment, and

Bibliography

169

pulmonary hypertension in sickle cell disease. Blood. 2008; 111: 402–

410.

Mrtinn H. Steinberg , Donald H. Moharey, Jennifer S. Tirnaur. Sickle

Hemoglobin structure and functional properties. Walters Kulwer july

2013.

Muscari M.E. Paediatric nursing; 4th edition .USA: Lippinctt Williams &

Wilkins. 2005.

Mutay Aslan, Thomas M. Ryan, Brian Adler, Tim M. Townes, Dale A.

Parks, J. Anthony Thompson, Albert Tousson, Mark T. Gladwin, Rakesh

P. Patel, Margaret M. Tarpey Ines Batinic-Haberle,C. Roger White, and

Bruce A. Freeman. Oxygen radical inhibition of nitric oxide-dependent

vascular function in sickle cell disease. PNAS. 2001; 98(2):15215–1522.

Myriam Taverna, Anne-Lise Marie, Jean-Paul Mira, and Bertrand

Guidet.Specific antioxidant properties of human serum albumin. Annals

of Intensive Care. 2013; 3: 4

Nagababu E., Fabry M.E., Nagel R.L., Rifkind J.M. Heme degradation and

oxidative stress in murine models for hemoglobinopathies:

Thalassemia, sickle cell disease and hemoglobin C disease. Blood Cells.

2008; 41: 61-66.

Bibliography

170

Nath K.A., Grande J.P., Croatt A.J., Frank E, Caplice NM, Hebbel

RP, Katusic ZS. Transgenic sickle mice are markedly sensitive to renal

ischemiareperfusion injury. Am J Pathol 2005; 166(4): 963-972.

Natta C. L., Chen L. C., Chow C. K. Selenium and glutathione peroxidase

levels in sickle cell anemia. Acta Haematol. 1990; 83: 130–132;.

Nayma Sultana, Noorzahan Begum, Shelina Begum, Sultana Ferdousi,

Taskina Ali. Oral supplementation of vitamin E reduces osmotic

Fragility of RBC in haemolytic anemic patients with G6PD deficiency.

Pak J Physiol. 2009; 5(1): 25-28.

Neil A., Warren D., Kouichi R. . Impaired pentose phosphate shunt

function in sickle cell disease: A potential mechanism for increased

Heinz body formation and membrane lipid peroxidation. 1983; 15 (1):

1-13.

Nitin John. A review of clinical Profile in sickle cell trait . OMJ. 2010; 25:

3-8.

Niki E., Noguchi N., Tsuchihashi H., Gotoh N. . Interaction among

vitamin C, Vitamin E, and beta carotene. Am J Clin Nutr. 1995; 62(suppl

6): 1322S-13226S.

Nur E., Brandjes D.P., Schnog J . Otten H.M., Fijnvandraat K., Schalkwijk

C.G., Biemond B.J. Plasma levels of advanced glycation end products are

Bibliography

171

associated with haemolysis-related organ complications in sickle cell

patients. Br J Haematol. 2010; 151: 62-69.

O. G. Arinola, J.A. Olaniyi, M.O. Akiibinu. Evaluation of Antioxidants

levels and trace elements status in Nigerian sickle cell disease patients

with plasmodium parasitaemia. Pakistan journal of Nutrition. 2008;

7(6): 766-169.

Oloopoenia L., Fredrick W., Greaves W., Adams R., Addo FE, Castro O..

Pneumococcal sepsis and meningitis in adults with sickle cell disease.

South Med J .1990; 83: 1002–1004.

Onyemailoh Obiageli Bridget and Obi Patrick Chinedu. Antioxidant

vitamins and glycatedhaemoglobin status in sickle cell anaemia. Al

Ameen J Med Sci. 2014; 7(2): 175-177.

Patrick B., Ellen B. Fung, David W. Killilea,Quig Jiang, Mark Hudes,

Jacquline, Madden, John Porter, Patricia Evansa, Elliott Vichinisky, and

Paul Harmatz. Oxidative stress and inflammation in iron-overloaded

patients with β-thalassaemia or sickle cell disease. Br J Haematol. 2006;

135(2): 254– 263.

Petra Niklowitz, Anka Sonnenschein, Bernd Janetzky, Werner Andler,

Platt O.S.. Sickle cell anemia as an inflammatory disease. J Clin Investig.

2000; 106: 337–8.

Bibliography

172

Prakash S. Hundekar, Aadinath N. Suryakar, Aarti C. Karnik, Rajesh

Valvi, Rahul A. Ghone, Sonali S. Bhagat The Effect of Antioxidant

Supplementation on the Oxidant And Antioxidant Status in Sickle

Cell Anaemia Journal of Clinical and Diagnostic Research. 2011

(Suppl-2); 5(7): 1339-1342.

R. Marouf, O. Mojiminiyi, N. Abdella, M. Kortom, A.L. Wazzan.

Comparision of renal function marker in Kuwaiti patients with sikle

cell disease.J Clin pathol. 2006; 59: 345-351.

R.B. Gupta Sickle Cell Disease in Central India - Need for Micro Level

Planning. 2004.

Raj N. verma, Vipul N. Mankind, Danna D., Lucy D., Robert M . Depressed

erythrocyte glutathione reductase activity in sickle cell disease. The

American journal of clinical nutrition. 1983; 38: 884-887.

Rana M.W. Hasanato . Zinc and antioxidant vitamin deficiency in

patients with severe sickle cell anemia, Ann Saudi Med. 2006; 26(1):

17-21.

Rdha Raghupathy , Henny H. Billett. Promising therapies in sickle cell

disease. Cardiovascular & haematological disorder drug targets. 2009;

9: 1-8.

Bibliography

173

Ren H., Ghebremeskel K., Okpala I., Lee A., Ibegbulam O., Crawford M.

Patients with sickle cell disease have reduced blood antioxidant

protection. Nt J Vitam Nutr Res. 2008; 78(3): 139-47.

Richard Rokyta, Anna Yamamotova, Rchard Sulc, Adislav Trefil, Jaroslav

Racek, Vladislav Treska. Assessment of biochemical markers in

patients with pain of vascular origin. Clin Exp Med. 2008; 8: 199-206.

Roche M., Rondeau P., Singh N.R., Tarnus E., Bourdon E. The antioxidant

properties of serum albumin. FEBS Lett. 2008; 582(1): 783–1787.

Ruchaneekorn W. Kalpravidh, Thongchai Tangjaidee, Suneerat

Hatairaktham, Ratiya Charoensakdi, Narumol Panichkul, Noppadol

Siritanaratkul, and Suthat Fucharoen. Glutathione Redox System in 𝛽-

Thalassemia/Hb E Patients. The Scientific World Journal. 2013: 7.

S. Richard, H.H. Billett. Liver function tests in sickle cell disease. Clin.

Lab. Haem. 2002; 24: 21-27.

Sanjana Bhagat , Pradeep Kumar Patra , Amar Singh Thakur. Association

of Inflammatory Biomarker C-Reactive Protein, Lipid Peroxidation and

Antioxidant Capacity Marker with HbF Level in Sickle Cell Disease

Patients from Chattisgarh. Ind J Clin Biochem. 2012; 27(4): 394–399

Sanjeev Shyam Rao, Jagdish Prasad Goyal, S.V. Raghunath, Vijay B. Shah.

Hematological profile of sickle cell disease from South Gujarat, India.

Hematology Report. 2012; 4(2): 8.

Bibliography

174

Santos C.X.C., Anjos E.l., Augusto O. Uric acid oxidation by peroxynitrite:

multiple reactions, free radical formation, and amplification of lipid

oxidation. Arch Biochem Biophys. 1999; 372: 285-294.

Schall J. I. , Zemel B.S., Kawchak D.A., Ohene‑Frempong K., Stallings V.A.

Vitamin A status, hospitalizations, and other outcomes in young

children with sickle cell disease. J Pediatr. 2004; 145: 99‑106.

Schnog J.B., Mac Gillavry M.R., Van Zanten A.P., Meijers J.C., Rojer R.A.,

Duits A.J., Ten Cate H., Brandjes D.P. . Protein C and S and inflammation

in sickle cell disease. AmJ Hematol. 2004; 76: 26–32.

Schulz G. E., Schirmer R.H., Pai E. FAD- binding site of glutathione

reductase . J. Mol Bio. 1982; 160 : 287-308.

S.E. Cox , V. L. Esperance, J. Makani , D. Soka, C.M. Hill, F.J. Kirkham.

Nocturnal haemoglobin saturation variability is asoociated with

vitamin C deficiency in Tanzanian children with sickle cell anemia. Acta

peadiatrica. 2011 ;100: 594-597.

Seema Tripathi, Rakesh Dadsena, Anil Kumar. Study of certain

Biochemical parameters in patients of sickle cell anemia. Advance of

bioresearch. 2011; 2(2): 79-81.

Sen C. K. Oxidants and antioxidants in exercise. Journal of applied

physiology(Bethesda, Md. : 1985). 1995; 79(3): 675-86.

Bibliography

175

Serjeant G.R. The clinical features of sickle cell disease. In: Clinical

Studies, ed by Bearn AG, Black DAK, Hiatt HH. North-Holland

Publishing Company. 1974; 4: 59.

Serjeant G.R.. Sickle Cell Disease. Lancet. 1997; 350: 725-730.

Sevanian K.J., Davies and P. Hochstein. Serum urate as an antioxidant for

ascorbic acid. American Journal of Clinical Nutrition. 1991; 54: 1129S-

1134S.

Sheng K., Shariff M., Hebbel R.P. Comparative oxidation of hemoglobins

A and S. Blood. 1998; 91(9): 3467-3470.

Shuchismita Behera, Sujata Dixit, Gandham Bulliyya, Shatanu Kumar

Kar. Vitamin A status and hematological values in sickle cell disorder

cases. Indian Journal of Medical Sciences. 2012; 66 (7-8): 169-74.

Silvia Maria Meira Magalhães. Oxidative status in sickle cell anemia. Rev

Bras Hematol Hemoter. 2011; 33(3): 172-177.

Solovey A., Lin Y., Browne P., Choong S. Wayner E., Hebbel R.P.

Circulating activated endothelial cells in sickle cell anemia. N Engl J

Med. 1997; 337:1584.

Somjee S.S., Warrier R.P., Thomson J.L., Ory-Ascani J., Hempe J.M.

Advanced glycation end-products in sickle cell anaemia. Br J Haematol

2005; 128(1): 112-118.

Bibliography

176

Squadrito G.L., Cueto R., Splenser A.E., Valavanidis A., Zhang H., Uppu

R.M., Pryor W.A. .Reaction of uric acid with peroxynitrite and

implications for the mechanism of neuroprotection by uric acid. Arch

Biochem Biophys. 2000; 376(2): 333-7.

Stefan Marklund And Gudrun Marklund. Involvement of the Superoxide

Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay

for Superoxide Dismutase. Eur. J. Biochem. 1974; 47: 469-474.

Stephen C., Jerlinda G.C., Andre D., Lindsey B., Vered, Mojibade N., Dylan,

Sherraine Griffin, Tara, Malcolm, Micheal R. Sickle hemoglobiin normal

coupling amomg erythrocyte O2 content, glycolysis , and antioxidant

capacity. Blood. 2013; 121(9): 1651-1662.

Stuart M.J., Nagel R.L.. Sickle-cell disease. Lancet. 2004; 364 : 1343-60.

Stone W.L., Payne P.H., Adebonojo F.O. Plasma vitamin E and low plasma

lipoprotein levels in sickle cell anemia patients. J Assoc Acad Minor

Physician. 1990;1(2): 12-6.

Suba Krishnan, Yamaja Setty, Suhita G. Betal,Vaidyula Vijender, Koneti

Rao,Carlton Dampier and Marie Stuart. .Increased levels of the

inflammatory biomarker C-reactive protein at baseline are associated

with childhood sickle cell vasocclusive crises. British Journal of

Haematology. 2009; 148: 797–804.

Bibliography

177

Subhash Banerjee, Charles Owen, Sanjiv Chopra. Sickle cell hepatopathy.

Jhep.2001; 1021-1028.

Switzer J.A., Hess D.C., Nichols F.T., Adams R.J. Pathophysiology and

treatment of stroke in sickle-cell disease: present and future. Lancet

Neurol. 2006; 5: 501-512.

Sylvie A. Akohoue, Sadhna shankar, Ginger L. Milne, Jason Morrow, Kong

Y. Taiwo Kotila, Kayode Adedapo, Aduragbenro Adedapo, Olayiwola

Oluwasola, Eyitayo Fakunle, Biobele Brown. Liver dysfunction in

steady state sickle cell disease. Annals of Hepatology. 2005; 4(4): 261-

263.

Tanveer Jilani and Mohammad Perwaiz Iqbal. Does vitamin E have a

role in treatment and prevention of anemia’s?. Pak. J. Pharm. Sci. 2011;

Vol.24 (2) : 237-242.

Temme E.H.M., Zhang J., Schouten E.G., & Kesteloot H. Serum bilirubin

and 10-year mortality risk in a Belgian population. Cancer Causes and

Control. 2001; 12: 887-894.

Thakur S. Y. KHAN, G. P. LITTARRU. TBARS level in socioeconomical

poor rural sickle cell patients of bilaspur zone of chhattisgarh state.

2011; 2(3): 3.

Thomas Menke. Enrichment of coenzyme Q10 in plasma and blood cells:

defense against oxidative damage. Int. J. biol. Sci. 2007;3.

Bibliography

178

Trine Juul, Anna Malolepszy, Karen Dybkær, Rune Kidmose, Jan Trige

Rasmussen, Gregers Rom Andersen, Hans Erik Johnsen, Jan-Elo

Jørgensen, and Stig Uggerhoj Andersen. The in vivo toxicity of

hydroxyurea depends on its direct target Catalase. Journal of Biological

chemistry. 2010; 285: 28.

Van Beers E.J., Van Tuijn C.F., Mac Gillavry M.R., Vander G.A., Schnog J.J.,

Biemond B.J. . Sickle cell diseaserelated organ damage occurs

irrespective of pain rate: implications for clinical practice.

Haematologica. 2008; 93(5): 757-760.

Vanessa Cumming, Susanna Ali, Terrence Forrester, Karen Roye-Green

and Marvin Reid. Asymptomatic bacteriuria in sickle cell disease: a

cross-sectional study. BMC infectious diseases. 2006; 6: 46.

Vigusin D.M., Pepys, M.B. & Hawkins, P.N. .Metabolic and scintigraphic

studies of radioiodanated human C- reactive protein in health and

disease. Journal of Clinical investigation. 1993; 91: 1351-1357.

Viktoria Jeney, Jozsef Balla, Akihiro Yachie, Zsuzsa Varga, Gregory M.

Vercellotti, John W. Eaton and Gyorgy Balla. Pro-oxidant and cytotoxic

effects of circulating heme. Blood. 2002; 100: 879-887.

Wali U. , Yedu, M.H., samila B., And Jiya N.M. .Serum antioxidant vitamins

level in children with sickle cell anemia in Sokoto western Nigeria.

Bajopas. 2013; 6(1).

Bibliography

179

Wang W.C., Greer J.P., Foerster J., Lukens J.N., Rodgers G.M., Paraskevas

F., Glader B. (eds). .Sickle cell anemia and other sickling syndromes.

Wintrobe’s clinical hematology. 11th ed. Philadelphia: Lippincott

Williams and Wilkins; 2004:1264–1311.

Weatherall D.J., Clegg J.B., Blankson J., McNeil J.R. . A new sickling

disorder resulting from interaction of the genes of haemoglobin S and

alpha-thalassaemia. Br J Hematol. 1969; 17: 517-526.

Wood K. C. & Graner D. N. . sickle cell disease: role of reactive oxygen

species and nitrogen metabolites. Clinc exp pharmacol physiol. 2007;

34: 926-932.

Xiaomei Niu, Mehdi Nouraie, Andrew Campbell, Sohail Rana, Caterina P.

Minniti, Craig Sable, Deepika Darbari, Niti Dham, N. Scott Reading, Josef

T. Prchal, Gregory J. Kato, Mark T. Gladwin,Oswaldo L. Castro, Victor R.

Gordeuk. Angiogenic and Inflammatory Markers of Cardiopulmonary

Changes in Children and Adolescents with Sickle Cell Disease. 2009;

4(11): 7956.

Yoshihito Iuchi Yamaguchi University Japan. Anemia Caused by

Oxidative Stress. 2005.

Young I.S., Woodside J.V. Antioxidants in health and disease. J Clin

Pathol .2001; 54:176–186.

Bibliography

180

Yu B.P. Cellular defenses against damage from reactive oxygen

species. Physiological Reviews. 2007; 74: 139–162.

Yung G.L., Channick R.N., Fedullo P.F., Auger W.R., Kerr K.M., Jamieson

S.W., Successful pulmonary thromboendarterectomy in two patients

with sickle cell disease. Am J Respir Crit Care Med. 1998; 157: 1690-3.